- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.99 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 15 x FMT: FORMIC ACID(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Popovic, B. et al., Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13R alpha 1 and IL-13R alpha 2. J. Mol. Biol. (2017)
- Release Date
- 2016-12-21
- Peptides
- Interleukin-13: A
tralokinumab FAb digest VH: B
tralokiumab FAb digest VL: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
HC
L
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.99 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 15 x FMT: FORMIC ACID(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Popovic, B. et al., Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13R alpha 1 and IL-13R alpha 2. J. Mol. Biol. (2017)
- Release Date
- 2016-12-21
- Peptides
- Interleukin-13: A
tralokinumab FAb digest VH: B
tralokiumab FAb digest VL: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
HC
L